EVI1 Promotes the Proliferation and Invasive Properties of Human Head and Neck Squamous Cell Carcinoma Cells

Head and neck squamous cell carcinoma (HNSCC) is a frequent malignancy with a poor prognosis. So far, the EGFR inhibitor cetuximab is the only approved targeted therapy. A deeper understanding of the molecular and genetic basis of HNSCC is needed to identify additional targets for rationally designe...

Descripción completa

Detalles Bibliográficos
Autores principales: Grandits, Alexander Michael, Bromberger, Sophie, Heller, Gerwin, Reinoehl, Barbara Andrea, Tomasich, Erwin, Schossleitner, Klaudia, Berghoff, Anna Sophie, Fuereder, Thorsten, Wieser, Rotraud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835242/
https://www.ncbi.nlm.nih.gov/pubmed/35162973
http://dx.doi.org/10.3390/ijms23031050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835242/
https://www.ncbi.nlm.nih.gov/pubmed/35162973
http://dx.doi.org/10.3390/ijms23031050

Ejemplares similares